Uncertain Impacts of DEA’s Potential Cannabis Rescheduling The DEA may soon move cannabis from Schedule I to Schedule III, a change suggested by Smart Approaches to Marijuana (SAM). This shift could redefine regulatory landscapes, impacting research and medical use. However, the broader effects on the industry are unclear, as this reclassification introduces new regulatory frameworks rather than simply deregulating the substance. The industry awaits further details on how this decision will reshape cannabis policy and business operations. https://www.marijuanamoment.net/marijuana-rescheduling-announcement-coming-very-soon-as-early-as-this-week-opposition-group-says/